vistabel, 4 unitati allergan/0,1 ml
allergan pharmaceuticals ireland ltd. - irlanda - toxina botulinica de tip a unui - pulb. pt. sol. inj. - 4 unitati allergan/0,1ml - miorelaxante periferice alte miorelaxante cu actiune periferica
plerixafor accord
accord healthcare s.l.u. - plerixafor - multiple myeloma; hematopoietic stem cell transplantation - imunostimulante, - adult patientsplerixafor accord is indicated in combination with granulocyte-colony stimulating factor (g-csf) to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in adult patients with lymphoma or multiple myeloma whose cells mobilise poorly (see section 4. paediatric patients (1 to less than 18 years)plerixafor accord is indicated in combination with g-csf to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in children with lymphoma or solid malignant tumours, either:- pre-emptively, when circulating stem cell count on the predicted day of collection after adequate mobilization with g-csf (with or without chemotherapy) is expected to be insufficient with regards to desired hematopoietic stem cells yield, or- who previously failed to collect sufficient haematopoietic stem cells (see section 4.
vistabel, 4 unitati allergan/0,1 ml
allergan pharmaceuticals ireland ltd. - irlanda - toxina botulinica de tip a unui - pulb. pt. sol. inj. - 4 unitati allergan/0,1ml - miorelaxante periferice alte miorelaxante cu actiune periferica
sitagliptin/metformin sandoz 50 mg/1000 mg
rontis hellas medical and pharmaceutical products s.a. - grecia - combinatii (sitagliptinum+metforminum) - compr. film. - 50mg/1000mg - analogi ai glp-1 combinatii de antidiabetice orale
flutiform 50 micrograme/5 micrograme
mundipharma dc bv - olanda - combinatii (fluticasonum+formoterolum) - susp. de inhalat presurizata - 50micrograme/5micrograme - adrenergice inhalante adrenergice si alte med. pt. trat. bolilor obstructive c.r
flutiform 125 micrograme/5 micrograme
mundipharma dc bv - olanda - combinatii (fluticasonum+formoterolum) - susp. de inhalat presurizata - 125micrograme/5micrograme - adrenergice inhalante adrenergice si alte med. pt. trat. bolilor obstructive c.r
flutiform 250 micrograme/10 micrograme
mundipharma dc bv - olanda - combinatii (fluticasonum+formoterolum) - susp. de inhalat presurizata - 250micrograme/10micrograme - adrenergice inhalante adrenergice si alte med. pt. trat. bolilor obstructive c.r
tandesar 32 mg
sun pharmaceutical industries europe b.v. - olanda - candesartanum cilexetil - compr. - 32mg - antagonisti de angiotensina ii antagonisti de angiotensina ii
avandamet
smithkline beecham plc - rosiglitazonă, clorhidrat de metformină - diabetul zaharat, tip 2 - medicamente utilizate în diabet - avandamet este indicat în tratamentul diabetului zaharat de tip 2 pacienți, în special al pacienților supraponderali:care sunt în imposibilitatea de a obține un control glicemic suficient la doza maximă tolerată de metformină administrată oral în monoterapie. în terapie orală triplă cu derivați de sulfoniluree, la pacienții cu control glicemic insuficient în ciuda terapiei orale duble cu doza maximă tolerată de metformin și o sulfoniluree (vezi pct. 4.
prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics
novartis vaccines and diagnostics s.r.l. - virusul gripei de suprafață (hemaglutinină și neuraminidază) de tulpina a / vietnam / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - vaccinuri - imunizarea activă împotriva subtipului h5n1 al virusului gripal a. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.